Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graça M Dores

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Drugs - Real World Outcomes|March 15, 2021
Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019Shaokui Wei, Manette T Niu, Graça M Dores
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldFarin Kamangar, Graça M Dores, William F Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2023
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldFarin Kamangar, Graça M Dores, William F Anderson
Journal of Pharmaceutical Health Care and Sciences|January 1, 2020
Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting SystemGraça M Dores, Silvia Perez-Vilar, Manette T Niu
JAMA Network Open|August 15, 2019
Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration's Adverse Event Reporting System, 2010-2017Graça M Dores, Marthe Bryant-Genevier, Silvia Perez-Vilar
Blood|April 6, 2021
The bidirectional increased risk of B-cell lymphoma and T-cell lymphomaDai Chihara, Graça M Dores, Christopher R Flowers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United StatesHouda Boukheris, Rochelle E Curtis, Charles E Land, et al.
American Journal of Hematology|May 29, 2021
Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucelGraça M Dores, Christopher Jason, Manette T Niu, et al.
Journal of Chemotherapy (Florence, Italy)|October 6, 2023
Varicella zoster virus reactivation reported with isatuximab useMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
BMC Cancer|April 18, 2015
A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010Graça M Dores, Osama Qubaiah, Ankur Mody, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Drugs - Real World Outcomes|March 15, 2021
Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019Shaokui Wei, Manette T Niu, Graça M Dores
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldFarin Kamangar, Graça M Dores, William F Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2023
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldFarin Kamangar, Graça M Dores, William F Anderson
Journal of Pharmaceutical Health Care and Sciences|January 1, 2020
Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting SystemGraça M Dores, Silvia Perez-Vilar, Manette T Niu
JAMA Network Open|August 15, 2019
Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration's Adverse Event Reporting System, 2010-2017Graça M Dores, Marthe Bryant-Genevier, Silvia Perez-Vilar
Blood|April 6, 2021
The bidirectional increased risk of B-cell lymphoma and T-cell lymphomaDai Chihara, Graça M Dores, Christopher R Flowers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United StatesHouda Boukheris, Rochelle E Curtis, Charles E Land, et al.
American Journal of Hematology|May 29, 2021
Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucelGraça M Dores, Christopher Jason, Manette T Niu, et al.
Journal of Chemotherapy (Florence, Italy)|October 6, 2023
Varicella zoster virus reactivation reported with isatuximab useMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
BMC Cancer|April 18, 2015
A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010Graça M Dores, Osama Qubaiah, Ankur Mody, et al.
Pageof 7